rasagiline has been researched along with Cognitive Decline in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Choudhry, A; Davis, MD; Elm, JJ; Hauser, RA; Pagan, F; Weintraub, D | 1 |
| Csóka, M; Domján, G; Kellős, É; Molnár, S | 1 |
1 trial(s) available for rasagiline and Cognitive Decline
| Article | Year |
|---|---|
Rasagiline for mild cognitive impairment in Parkinson's disease: A placebo-controlled trial.
Topics: Aged; Cognitive Dysfunction; Dopamine Agents; Double-Blind Method; Drug Therapy, Combination; Female; Humans; Indans; Male; Middle Aged; Monoamine Oxidase Inhibitors; Outcome Assessment, Health Care; Parkinson Disease | 2016 |
1 other study(ies) available for rasagiline and Cognitive Decline
| Article | Year |
|---|---|
[Problem solving care models for Parkinson's disease].
Topics: Accidental Falls; Activities of Daily Living; Aged, 80 and over; Antiparkinson Agents; Cognitive Dysfunction; Constipation; Deglutition Disorders; Eating; Female; Hallucinations; Holistic Nursing; Humans; Indans; Neuroprotective Agents; Parkinson Disease; Patient Care Team; Pneumonia; Pressure Ulcer; Problem Solving; Psychomotor Agitation; Quality of Life; Skin Care; Sleep Initiation and Maintenance Disorders; Walking | 2016 |